CPEX Pharmaceuticals Inc said it appointed Lance Berman as its chief medical officer, effective February 2, 2009. Berman succeeds Robert Stote, who has been serving as the chief medical officer of CPEX since its spin-off from Bentley Pharmaceuticals, Inc. in June of 2008. Stote, who is retiring, will continue as a clinical consultant for CPEX.